SmartCraft ASA (SMCRT) - Q3 2024: Continued high growth and strong cash flow, margins impacted by acquisitions and one-off items Read more about SmartCraft ASA (SMCRT) - Q3 2024: Continued high growth and strong cash flow, margins impacted by acquisitions and one-off items
Cost reductions offseting lower volumes - New cost initiatives and record New Business Wins YTD support long-term growth and profitability Read more about Cost reductions offseting lower volumes - New cost initiatives and record New Business Wins YTD support long-term growth and profitability
Pressemelding: SATS rapporterer inntekstvekst på 8 prosent Read more about Pressemelding: SATS rapporterer inntekstvekst på 8 prosent
Lytix Biopharma - Update from licensing partner Verrica Pharmaceuticals Read more about Lytix Biopharma - Update from licensing partner Verrica Pharmaceuticals
argenx to Participate at Upcoming Investor Conferences Read more about argenx to Participate at Upcoming Investor Conferences
Strong biological performance in the Faroe Islands and successful de-risking in Scotland Read more about Strong biological performance in the Faroe Islands and successful de-risking in Scotland
LINK Mobility – Q3 24 – Growth in line with expectations Read more about LINK Mobility – Q3 24 – Growth in line with expectations